Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Exocell presents humanized MAb for diabetic nephropathy

July 10, 1997

Novel hemoregulatory compounds from SKB

July 10, 1997

Update on Pfizer/Ligand treatments for osteoporosis and breast cancer

July 9, 1997

MGI Pharma launches INFeD for anemia in cancer patients

July 9, 1997

Oxford GlycoSciences licenses compound for treatment of glycolipid storage disorders

July 9, 1997

Didronel PMO now available for expanded use in the U.K.

July 9, 1997

Lilly reports new salt of PKC inhibitor with improved pharmaceutical properties

July 9, 1997

SmithKline Beecham focuses on hemoregulatory compounds

July 9, 1997

Senetek seeks Danish approval of erectile dysfunction therapy

July 8, 1997

Bioisosteres of sulfonylureas prepared by Belgian investigators

July 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026